Pre-immunization with autoantigens confers resistance in experimental models of autoimmune diseases. Since non-self molecules can also be protective, it is conceivable that part of the effect rests on a non-specific attenuation of the immune response. This study is aimed at identifying mechanisms by which pre-immunization with a moiety suspended in incomplete Freund's adjuvant (IFA) protects from experimental allergic encephalomyelitis (EAE). Lewis rats were immunized with each of either concanavalin A, lipopolysaccharide, bovine serum albumin, 70 or 65 kDa heat shock proteins, or myelin basic protein. All moieties were given in IFA 3 weeks prior to EAE induction. Serial cytofluorimetric monitoring of B cells and of the αβTCR ⍣ , CD4 ⍣ , CD8 ⍣ , CD45 high and CD45 low cells was performed. IFN-γ and IgG1 production was evaluated in parallel. All moieties were able to attenuate or abrogate the clinical signs of EAE. At day 4 and 10 after EAE induction, the surface expression of the CD4 molecule was down-regulated on T lymphocytes. This down-regulation was most evident in animals with the highest degree of clinical protection. By day 21 postimmunization, CD4 expression was restored. The same animals also showed an increase in the B cell percentage and T h 2-related IgG1 production while IFN-γ secretion was reduced. Pre-immunization with diverse antigens suspended in IFA confers resistance to EAE induction. The down-regulation of the CD4 co-receptor accompanied by events suggestive of an immune deviation may be a general mechanism that contributes to the protection.
Introduction
In animal models of autoimmune disease pre-immunization (EAE) (11) (12) (13) (14) . Protective properties intrinsic of microbial constituents have been hypothesized in EAE (13-14), immune with the autoantigen(s) confers protection by inducing specific unresponsiveness or deletion of the autoantigen-reactive deviation events have been observed in experimental models of diabetes (10) while superantigens induce protection cells. This kind of antigen-specific tolerance can be attained by the administration of high doses of antigens through through anergy/deletion (15-16). More recently, when synthetic peptides were used to compete for binding to the I-A g7 mechanisms of high dose suppression (1) . Tolerance can also be achieved by suspending the autoantigen in incomplete molecule in an attempt to prevent disease in the NOD mouse, it was shown that the therapeutic effect was not caused by Freund's adjuvant (IFA) (2) . In the latter procedure, part of the resistance may be neither agent-specific nor diseasethe blockade of MHC presentation. Rather, it appeared to be related to the immunogenicity of the 'blocking' peptide through specific and the mechanisms involved in this protection are not clearly defined (3) . In fact, pre-immunization with microbial undefined mechanisms (17). Altogether, the above experiments suggest that strong antigenic stimuli may carry a constituents and mitogens also prevents the development of various experimental models of autoimmune disease including protective potential per se, promoting wide-scale tolerogenic events (3) . If this is the case, such events should be detectable adjuvant arthritis (4-6), diabetes in non-obese diabetic (NOD) mice (7-11) and experimental allergic encephalomyelitis in all protected animals, irrespective of the moiety employed.
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Transmitting editor: G. Doria Received 26 April 1996, accepted 25 December 1996 To assess this hypothesis, we immunized Lewis rats, before were seeded at a concentration of 1ϫ10 6 cells/ml in roundbottomed 96-well plates and incubated at 10% CO 2 Tissue culture medium and supplements were purchased IFN-γ and IgG1 detection from Gibco/BRL (Cergy-Pontoise, France). All the antibodies At the same time points, after 72 h in culture in the presence were obtained from Serotec (Kidlington, UK).
or absence of Con A, supernatants were collected for IFN-γ production assessed by a commercial ELISA kit (Biosource, Pre-immunization and EAE induction Camarillo, CA; IgG1 levels were detected by a Radial ImmunoSix groups of Lewis rats (15 animals each) were pre-immunDiffusion assay (The Binding Site, Birmingham, UK) on the ized i.p. with the following agents, each one diluted in PBS same supernatants. (50 µl) and emulsified in IFA (50 µl), at a dose of 50 µg: LPS, BSA, HSP70, HSP65, Con A and MBP. As controls, two groups Results of animals (15 each) received: PBS (100 µl) and PBS (50 µl) in IFA (50 µl). Results were confirmed in three different sets All agents were able to reduce the incidence and severity of of experiments. EAE ( Fig. 1A and B) . The most effective pre-treatments were At day 18 after pre-immunization, they were actively immunCon A and MBP followed, with decreasing efficacy, by HSP65, ized s.c. in the foot pads with 50 µg guinea pig MBP in 50 µl BSA, HSP70 and LPS. On the contrary, the controls (PBS and PBS emulsified with an equal volume of complete Freund's PBS/IFA groups) developed a full EAE. In two experiments adjuvant (CFA) containing 2 mg/ml M. tuberculosis. As addiout of three, the PBS/IFA group appeared to develop a tional control groups, other animals received the above predisease that was slightly more pronounced than that of immunization moieties but were not immunized at day 18. animals in the PBS group. At present, the significance of this The animals were weighted and evaluated for the developobservation is unclear. ment of neurological signs daily according to the following During the pre-immunization phase, the serial analysis of scale: grade 0, no abnormality; grade 1, flaccidity of the tail; lymphocyte subpopulations from popliteal and inguinal lymph grade 2, unsteady gait; grade 3, hind limb paralysis; grade nodes did not show significant modifications of αβTCR, CD4, 4, hind and fore limb paralysis or death.
CD8, CD45 high and CD45 low molecule expression as well as of IFN-γ and IgG1 production. Cell isolation and culture At day 4 post-immunization, CD4 molecules appeared down-regulated on cells derived from Con A, MBP, HSP65 Animals were sacrificed at day 10 and 18 after pre-immunization and at day 4, 10 and 21 post-immunization (and at and HSP70 pre-treated animals, reaching the maximal level at day 10 post-immunization. At this time point, the downequivalent time points in the non-immunized groups) for cytofluorimetric studies and for assessment of IFN-γ and IgG1 regulation became evident also in cells from BSA pre-immunized rats, while it remained not significant in the LPS group production. Popliteal and inguinal lymph nodes were isolated and homogenized. Cell suspensions were resuspended in (Fig. 2) . By day 21, the molecule expression was restored. Interestingly, the down-regulation of the CD4 co-receptor was Dulbecco's modified Eagle's medium supplemented with 1% penicillin/streptomycin (50 U/ml and 50 mg/ml respectively), most pronounced in those groups with the highest degree of clinical protection (in particular HSP65-, MBP-and ConA-1% sodium pyruvate (1 mM), 1% L-glutamine (2 mM), 1% non-essential amino acids, 1% fresh autologous serum; they pretreated rats). We did not observe changes in the expression of the CD4 molecule in the groups of animals receiving the adult Lewis rats. Though with different degrees of efficacy, all agents conferred resistance. Since it is hardly conceivable pre-immunizing moieties in IFA without subsequent immunization. In all cases, the percentage of CD4 ϩ T cells did not that all the non-self moieties used in this study have a direct or indirect pathogenetic role in EAE, specific mechanisms of change. Absolute numbers of white cells did not seem to be affected since the spleen weight and the lymph node volumes tolerization of autoreactive effectors are unlikely. A recent report substantiates this view. In experiments designed to did not vary between groups.
The B cell subset was analyzed in HSP65, Con A and MBP prevent diabetes in NOD mice by blocking the MHC presentation of an autoantigenic peptide, Vaysburd et al. demonstrated pre-treated rats; an increase in the percentage of OX33-positive cells was observed in these groups compared to that protection did not depend on the ability of a peptide to compete for MHC binding. Rather, prevention was related controls, again at day 10 post-immunization (Fig. 3) . At this time point, a reduction of IFN-γ levels was detected in to the immunogenicity of the competitor peptide through unidentified mechanisms (17). protected animals (Fig. 4) . With the exception of MBP, protection also correlated with an increased IgG1 production (Fig. 5) .
We therefore sought to identify general modifications which could account for an attenuation of the T cell reactivity The proliferative response to the pre-immunizing moieties as well as to purified protein derivative was not affected in all following an immunogenic stimulus, confirming that common tolerogenic events are operative in these models. groups at any of the time points studied; the only exception was the MBP pre-treated group that showed a decrease in
The serial cytofluorimetric analysis showed a down-regulation of the CD4 co-receptor in protected animals. This may the response to MBP at day 10 post-immunization (data not shown).
account for a modulation of the helper/inducer subset given the pivotal role of CD4 molecules in T cell activation (19-23).
The effectiveness of similar mechanisms has been already Discussion described for the cytotoxic/suppressor subset where the lowering of the CD8 expression on mature T cells can convert In the present study, i.p. pre-immunization with foreign antigens, mitogens and the autoantigen MBP prevents EAE in TCR agonists to antagonists (24). Others have described peripheral T cell tolerance linked to the down-regulation of both TCR and co-receptor, again in the cytotoxic/suppressor subset (25) . The observation of a down-regulation of the CD4 expression HSP65 and Con A at day 10 after the encephalitogenic challenge.
also in the MBP pre-immunized animals strengthens the idea that this is a general mechanism of tolerization, linked to the immunogenicity of the pre-immunizing moiety, independent In animals pre-treated with all the other non-self moieties, and addictive to the specific tolerization of autoreactive proliferative responses were not affected. One possibility is effectors (1,2; and the decreased proliferative response to MBP in our experiments).
that the down-regulation of the CD4 co-receptor does not
